Pancreatic cancer is one of the deadliest cancers - tumors are often diagnosed at advanced stages of the disease and metastasize rapidly. This one-week discussion course will provide a comprehensive overview of clinical and biological aspects of pancreatic cancer with special emphasis on disease diagnosis and management, molecular pathways involved in tumor development and progression, mechanism-based therapeutic strategies, advanced research tools, and ethical concerns. Attendees will be able to interact with senior investigators on a one-to-one basis in an informal environment. Non-faculty students may be eligible for partial stipends, depending on stated need. Applications are invited from medical and graduate students, postdoctoral fellows, and faculty.
Andrew Aguirre, Dana-Farber Cancer Institute
Gregory Beatty, University of Pennsylvania - Perelman School of Medicine
Cosimo Commisso, Sanford Burnham Prebys Medical Discovery Institute
Edna Cukierman, Fox Chase Cancer Center / Temple Health
Brian M. Davis, University of Pittsburgh School of Medicine
David DeNardo, Washington University, St. Louis
Channing J.Der, University of North Carolina
Mikala Egeblad, Cold Spring Harbor Laboratory
Dannielle Engle, The Salk Institute for Biological Studies
Eugene J. Koay, MD Anderson Cancer Center
Costas A. Lyssiotis, University of Michigan
Florencia McAllister, MD Anderson Cancer Center
Oliver McDonald, Vanderbilt
Kenneth P. Olive, Columbia University
Eileen M. O'Reilly, Memorial Sloan Kettering Cancer Center
Rushika Perera, University of California San Francisco
Gloria Petersen, Mayo Clinic
Jonathan Preall, Cold Spring Harbor Laboratory
Andrew D. Rhim, University of Texas MD Anderson Cancer Center
Nicholas Roberts, Johns Hopkins School of Medicine
Mara H. Sherman, Oregon Health & Science University
Diane M. Simeone, NYU Langone Medical Center
Aatur D. Singhi, University of Pittsburgh Medical Center
Ben Stanger, University of Pennsylvania
Julie L. Sutcliffe, University of California Davis
Cullen Taniguchi, University of Texas MD Anderson Cancer Center
Course support may be provided by:
Scholarship funds are available for partial support of tuition on a merit basis. Please apply in writing when you apply stating the need for financial aid.
Cost (including board and lodging): $2,945
No fees are due until you have completed the full application process and are accepted into the course. Students accepted into the course should plan to arrive by early evening on Wednesday, June 15 and plan to depart in the morning of Thursday, June 23
Before applying, ensure you have:
- Personal statement/essay;
- Letter(s) of recommendation;
- Curriculum vitae/resume (optional);
- Financial aid request (optional).
More details.
This button links to a short form which confirms your interest in the course. No fees are due until you have completed the full application process and are accepted into the course.